{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:49:51Z","timestamp":1786718991838,"version":"build-2736575974"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Niger J Clin Pract"],"published-print":{"date-parts":[[2019]]},"DOI":"10.4103\/njcp.njcp_273_17","type":"journal-article","created":{"date-parts":[[2019,4,11]],"date-time":"2019-04-11T06:55:23Z","timestamp":1554965723000},"page":"534","source":"Crossref","is-referenced-by-count":10,"title":["Serological and virological markers of nigerian patients with hepatitis B infection"],"prefix":"10.4103","volume":"22","author":[{"given":"OA","family":"Lesi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RA","family":"Audu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AP","family":"Okwuraiwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"OO","family":"Adeleye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FA","family":"Ige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JC","family":"Iwuorah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1119-3077.255920-1","first-page":"163","volume-title":"Prevalence of hepatitis B virus infection in Nigeria, 2000-2013: A systematic review and meta-analysis","author":"Musa","year":"2015","journal-title":"Niger J Clin Pract","ISSN":"https:\/\/id.crossref.org\/issn\/1119-3077","issn-type":"print"},{"key":"key-10.4103\/1119-3077.255920-2","unstructured":"Federal Ministry of Health. National Survey of Viral Hepatitis B and C Infection in Nigeria; 2013."},{"key":"key-10.4103\/1119-3077.255920-3","first-page":"65","volume-title":"Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level","author":"Chen","year":"2006","journal-title":"JAMA"},{"key":"key-10.4103\/1119-3077.255920-4","first-page":"678","volume-title":"Predicting cirrhosis risk based on the level of circulating hepatitis B viral load","author":"Iloeje","year":"2006","journal-title":"Gastroenterology"},{"key":"key-10.4103\/1119-3077.255920-5","first-page":"2212","volume-title":"Global epidemiology of hepatitis B virus infection: New estimates of age-specific HBsAg seroprevalence and endemicity","author":"Ott","year":"2012","journal-title":"Vaccine"},{"key":"key-10.4103\/1119-3077.255920-6","first-page":"553","volume-title":"Diagnosis of hepatitis B virus infection through serological and virological markers","author":"Kao","year":"2008","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"key-10.4103\/1119-3077.255920-7","first-page":"1356","volume-title":"Chronic hepatitis B virus infection in Asian countries","author":"Merican","year":"2000","journal-title":"J Gastroenterol Hepatol"},{"key":"key-10.4103\/1119-3077.255920-8","first-page":"211","volume-title":"The Gambia Liver Cancer Study: Infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa","author":"Kirk","year":"2004","journal-title":"Hepatology"},{"key":"key-10.4103\/1119-3077.255920-9","unstructured":"World Health Organization 2015. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. Available from: www.who.int\/hepatitis\/publications\/hepatitis-b-guidelines\/en\/. [Last assessed 2017 Aug 29]."},{"key":"key-10.4103\/1119-3077.255920-10","unstructured":"World Health Organization (WHO). Global Hepatitis report 2017. Available from: www.who.int\/entity\/hepatitis\/publications\/global-hepatitis-report2017\/en\/- 30k. [Last accessed on 2017 Sep 4]."},{"key":"key-10.4103\/1119-3077.255920-11","first-page":"1","volume-title":"High prevalence of hepatitis B virus infection in the age range of 20-39 years old individuals in Lome","author":"Kolou","year":"2017","journal-title":"Open Virol J"},{"key":"key-10.4103\/1119-3077.255920-12","doi-asserted-by":"crossref","unstructured":"Kew MC. Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma. Pathol Biol 2010;58.4:273-7.","DOI":"10.1016\/j.patbio.2010.01.005"},{"key":"key-10.4103\/1119-3077.255920-13","unstructured":"Baig S. Gender disparity in infections of hepatitis B virus. 2009. J Coll Physicians Surg Pak. 2009;19:598-600."},{"key":"key-10.4103\/1119-3077.255920-14","first-page":"10","volume-title":"Hepatitis B virus DNA in serum from subjects with acute hepatitis B","author":"Krogsgaard","year":"1985","journal-title":"Hepatology"},{"key":"key-10.4103\/1119-3077.255920-15","first-page":"e30","volume-title":"Is mother-to-infant transmission the most important factor for persistent HBV infection?","author":"Li","year":"2015","journal-title":"Emerg Microbes Infect"},{"key":"key-10.4103\/1119-3077.255920-16","first-page":"e358","volume-title":"Mother-to-child transmission of hepatitis B virus in sub-Saharan Africa: Time to act","author":"Andersson","year":"2015","journal-title":"Lancet Glob Health"},{"key":"key-10.4103\/1119-3077.255920-17","first-page":"680","volume-title":"The value of quantitative detection of HBV-DNA amplified by PCR in the study of hepatitis B infection","author":"Jardi","year":"1996","journal-title":"J Hepatol"},{"key":"key-10.4103\/1119-3077.255920-18","first-page":"52","volume-title":"Worldwide epidemiology of HbeAg negative chronic hepatitis B and associated precore and core promoter variants","author":"Funk","year":"2002","journal-title":"J Viral Hepat"},{"key":"key-10.4103\/1119-3077.255920-19","first-page":"617","volume-title":"Hepatitis B e antigen-negative chronic hepatitis B","author":"Hadziyannis","year":"2001","journal-title":"Hepatology"},{"key":"key-10.4103\/1119-3077.255920-20","first-page":"168","volume-title":"Hepatitis B e antigen and the risk of hepatocellular carcinoma","author":"Yang","year":"2002","journal-title":"N Engl J Med"},{"key":"key-10.4103\/1119-3077.255920-21","first-page":"95","volume-title":"Viral load pattern among hepatitis B surface antigen-positive patients: Laboratory perspective and implications for therapy","author":"Iregbu","year":"2016","journal-title":"Ann Med Health Sci Res","ISSN":"https:\/\/id.crossref.org\/issn\/2141-9248","issn-type":"print"},{"key":"key-10.4103\/1119-3077.255920-22","first-page":"e559","volume-title":"Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: The Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study","author":"Lemoine","year":"2016","journal-title":"Lancet Global Health"}],"container-title":["Nigerian Journal of Clinical Practice"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:42:27Z","timestamp":1786714947000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/njcp.njcp_273_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"alternative-id":["255920"],"URL":"https:\/\/doi.org\/10.4103\/njcp.njcp_273_17","relation":{},"ISSN":["1119-3077"],"issn-type":[{"value":"1119-3077","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}